Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	220	135	49	156	180	146
Market Cap Growth	390.27%	176.07%	-68.73%	-13.14%	23.41%	-7.25%
Enterprise Value	240	224	144	245	238	157
PE Ratio	-	-17.14	-0.90	-2.21	-3.22	-2.20
PS Ratio	4.28	2.67	1.02	3.07	3.92	2.77
PB Ratio	-8.60	-1.27	-0.41	-1.90	-3.71	-23.81
P/FCF Ratio	-11.74	-18.29	-4.51	-4.61	-3.91	-2.39
P/OCF Ratio	-12.21	-21.14	-4.98	-4.74	-3.96	-2.42
EV/Sales Ratio	4.66	4.42	3.03	4.82	5.18	2.98
EV/EBITDA Ratio	-19.41	189.14	-3.65	-5.43	-6.04	-2.90
EV/EBIT Ratio	-18.11	-1371.58	-3.44	-5.09	-5.55	-2.75
EV/FCF Ratio	-12.49	-30.31	-13.31	-7.23	-5.17	-2.58
Debt / Equity Ratio	-3.17	-1.06	-1.04	-1.42	-1.84	-9.86
Debt / EBITDA Ratio	-6.73	95.24	-3.10	-2.59	-2.28	-1.12
Debt / FCF Ratio	-4.33	-15.26	-11.32	-3.44	-1.95	-0.99
Quick Ratio	5.73	1.77	0.81	1.83	1.84	3.37
Current Ratio	6.28	2.24	1.01	2.15	2.12	3.68
Asset Turnover	0.68	0.86	0.86	0.79	0.76	0.86
Interest Coverage	-1.80	-0.02	-3.37	-2.14	-3.28	-6.11
Return on Equity (ROE)	32.70%	7.40%	52.30%	113.80%	175.40%	371.70%
Return on Assets (ROA)	-37.90%	-13.40%	-98.10%	-110.20%	-92.50%	-107.90%
Return on Capital (ROIC)	-24.68%	-248.27%	-1003.24%	-100.31%	-104.73%	-97.14%
Earnings Yield	-13.06%	-5.84%	-111.37%	-45.15%	-31.01%	-45.45%
FCF Yield	-12.07%	-5.47%	-22.19%	-21.69%	-25.56%	-41.77%
Buyback Yield / Dilution	0.24%	-25.69%	-27.99%	-13.15%	-32.71%	-22.34%
Total Shareholder Return	0.24%	-25.69%	-27.99%	-13.15%	-32.71%	-22.34%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).